Eli Lilly and Company (TSX:LLY)
Canada · Delayed Price · Currency is CAD 48.29
-0.38 (-0.78%)
Nov 6, 2026, 4:00 PM EST
Eli Lilly and Company Ratios and Metrics
Market cap in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1,700,279 | 1,319,357 | 1,000,186 | 692,306 | 470,466 | 316,903 | |
Market Cap Growth | 45.23% | 31.91% | 44.47% | 47.15% | 48.46% | 62.48% |
Enterprise Value | 1,762,108 | 1,363,784 | 1,039,381 | 715,104 | 487,742 | 332,087 |
Last Close Price | 48.29 | 38.89 | 28.37 | 21.63 | - | - |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 33.30 | 46.62 | 65.64 | 100.04 | 55.66 | 44.86 |
PS Ratio | 13.85 | 14.76 | 15.43 | 15.36 | 12.18 | 8.84 |
PB Ratio | 29.74 | 36.26 | 48.71 | 48.26 | 32.26 | 27.35 |
P/TBV Ratio | 97.27 | 68.17 | 297.57 | - | - | - |
P/FCF Ratio | 60.92 | 107.25 | 184.88 | 661.90 | 60.65 | 41.35 |
P/OCF Ratio | 39.08 | 57.23 | 78.83 | 123.64 | 45.83 | 34.00 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 14.46 | 15.26 | 16.04 | 15.87 | 12.63 | 9.27 |
EV/EBITDA Ratio | 26.77 | 31.38 | 38.41 | 45.69 | 35.42 | 26.72 |
EV/EBIT Ratio | 28.21 | 33.49 | 42.39 | 52.44 | 41.65 | 31.72 |
EV/FCF Ratio | 63.13 | 110.86 | 192.12 | 683.70 | 62.88 | 43.33 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 1.23 | 1.65 | 2.44 | 2.44 | 1.52 | 1.85 |
Debt / EBITDA Ratio | 1.06 | 1.37 | 1.83 | 2.20 | 1.61 | 1.72 |
Debt / FCF Ratio | 2.52 | 4.89 | 9.25 | 33.42 | 2.86 | 2.80 |
Net Debt / Equity Ratio | 1.09 | 1.37 | 2.17 | 2.09 | 1.23 | 1.28 |
Net Debt / EBITDA Ratio | 0.94 | 1.15 | 1.65 | 1.92 | 1.30 | 1.20 |
Net Debt / FCF Ratio | 2.23 | 4.05 | 8.26 | 28.68 | 2.31 | 1.94 |
Asset Turnover | 0.66 | 0.68 | 0.63 | 0.60 | 0.58 | 0.59 |
Inventory Turnover | 0.93 | 1.04 | 1.26 | 1.41 | 1.62 | 1.77 |
Quick Ratio | 0.64 | 0.78 | 0.57 | 0.52 | 0.63 | 0.80 |
Current Ratio | 1.39 | 1.58 | 1.15 | 0.94 | 1.05 | 1.23 |
Return on Equity (ROE) | 86.02% | 101.16% | 84.26% | 48.43% | 62.67% | 74.52% |
Return on Assets (ROA) | 21.06% | 19.41% | 14.92% | 11.37% | 11.00% | 10.84% |
Return on Invested Capital (ROIC) | 42.68% | 43.74% | 35.54% | 27.99% | 33.88% | 36.42% |
Return on Capital Employed (ROCE) | 43.80% | 38.40% | 33.90% | 28.10% | 26.70% | 24.50% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 3.00% | 2.15% | 1.52% | 1.00% | 1.80% | 2.23% |
FCF Yield | 1.64% | 0.93% | 0.54% | 0.15% | 1.65% | 2.42% |
Dividend Yield | 0.51% | 0.56% | 0.67% | 0.78% | 1.01% | 1.23% |
Payout Ratio | 21.68% | 26.09% | 44.19% | 77.65% | 56.62% | 55.30% |
Buyback Yield / Dilution | 0.58% | 0.53% | -0.09% | 0.15% | 0.78% | 0.09% |
Total Shareholder Return | 1.09% | 1.09% | 0.58% | 0.92% | 1.79% | 1.32% |